| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5912325 | Multiple Sclerosis and Related Disorders | 2016 | 5 Pages |
Abstract
Treatment with methylprednisolone decreases EDSS score in RRMS relapse. The increase in EDSS is related to level of TM. The changes in level of TM and APC may be indicator for prognosis of MS or treatment modalities to MS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Ece Balkuv, Asuman Orhan Varoglu, Nihal Isik, Banu Isbilen, Saadettin Duruyen, Recep Basaran, Abdulkadir Kocer,